Chikungunya

A*STAR researchers find that ordinary communications between immune cells during chikungunya virus infection can drive joint inflammation seen in the disease.

During the 2018 outbreak in Southeastern Tanzania, there were four dengue virus serotypes and the chikungunya virus in circulation, say A*STAR researchers.

Targeted mutagenesis is being used to create live-attenuated vaccines against the chikungunya virus.

Malaria infections may be masking the extent of the emerging chikungunya epidemic

Insight into how symptoms of the chikungunya virus are triggered suggests existing
treatments could be repurposed to help infected patients

A failed treatment for chikungunya highlights the need for extreme caution when manipulating the immune system

Mild symptoms could mean that children are bringing the mosquito-borne disease to the playground

Researchers at A*STAR have joined forces to fight the Zika virus

The Chikungunya virus that has hit the Americas is less severe than the strain that wreaked havoc in La Reunion

Revelation of antiviral properties in the protein viperin could help virologists to contain the re-emerging chikungunya virus

Exploiting the early immune response in Chikungunya fever promises to provide protection

Patients with chikungunya fever experience persistent joint pain because their body produces high amounts of pro-inflammatory cytokines